Piedmont Investment Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,055
| Closed | -$282K | – | 469 |
|
|
2020
Q1 | $282K | Buy |
1,055
+23
| +2% | +$6.15K | 0.01% | 626 |
|
|
2019
Q4 | $334K | Buy |
+1,032
| New | +$334K | 0.01% | 702 |
|
|
2019
Q2 | – | Sell |
-943
| Closed | -$475K | – | 1146 |
|
|
2019
Q1 | $475K | Buy |
943
+19
| +2% | +$9.57K | 0.02% | 556 |
|
|
2018
Q4 | $455K | Buy |
924
+55
| +6% | +$27.1K | 0.02% | 492 |
|
|
2018
Q3 | $794K | Buy |
869
+747
| +612% | +$683K | 0.03% | 357 |
|
|
2018
Q2 | $89K | Buy |
+122
| New | +$89K | ﹤0.01% | 1123 |
|
|
2018
Q1 | – | Sell |
-2,158
| Closed | -$1.93M | – | 791 |
|
|
2017
Q4 | $1.93M | Sell |
2,158
-112
| -5% | -$100K | 0.04% | 257 |
|
|
2017
Q3 | $817K | Buy |
2,270
+34
| +2% | +$12.2K | 0.02% | 329 |
|
|
2017
Q2 | $656K | Buy |
2,236
+1,623
| +265% | +$476K | 0.01% | 359 |
|
|
2017
Q1 | $216K | Buy |
+613
| New | +$216K | ﹤0.01% | 390 |
|